Raytheon Technologies: a safe stock for an unsafe world
Defence spending is set to soar – that should be good news for aerospace heavyweight Raytheon Technologies.


Russia’s invasion of Ukraine has alerted democracies to the dangers of dictators with expansionist ambitions. The results will include strengthening of protective alliances and increased spending on defence. Germany, which has long undershot the Nato target of 2% GDP on defence, is now preparing to exceed that. Japan, which is conscious of China’s threats to invade democratic Taiwan and the South China Sea islands, has set a record defence budget for 2022. Australia is increasing its defence force by one-third.
Defence companies are thus likely to see sustained growth in orders. I recommended Lockheed Martin, the world’s largest defence company, in June 2020 (up around 22% since) and I am now recommending the world’s second-largest defence company – Raytheon Technologies (NYSE: RTX), which was formed by the merger of Raytheon and United Technologies in April 2020.
A wide range of products
Defence accounts for 65% of Raytheon’s sales, and this is likely to increase.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The group has four divisions: Pratt & Whitney produces commercial and military aero-engines. Key products include engines for the Airbus A320neo and A220 airliners, the F-35 and F-16 fighters, Apache helicopters and research on high-speed military engines.
Missiles & Defence makes the Patriot anti-missile systems (the world’s primary land-based system), naval missiles, hypersonic missiles, space sensors to detect missile launches, radars, and command and control systems.
Collins Aerospace makes aerospace avionics, structures and systems for Airbus, Boeing, Lockheed, Embraer and Dassault and for US submarines and destroyers.
Intelligence & Space, which again serves both military and commercial customers, covers airspace modernisation (surveillance, navigation, landing systems), battle management (command and control, land and satellite surveillance, electronic warfare planning and management) and hardening information systems against cyberattacks.
Developing new technologies
Raytheon’s research and development is focusing on areas including cyber-hardened connected systems (both commercial and battlespace), autonomy and artificial intelligence (unmanned aircraft, autonomous and semi-autonomous operations), propulsion (more sustainable commercial engines, next-generation military aircraft, hypersonics) and precision sensing and effects (space sensing, missiles and missile defence, directed energy weapons, electronic warfare). There are usually over 300 new ideas under assessment, with some gaining defence or commercial contracts.
Recent wins include a contract from the US Missile Defence Agency to develop and test the first interceptor to defeat hypersonic missile threats from Russia and China; an electro-optical system giving F-35 pilots an unprecedented 360-degree situational awareness and survivability; a joint Lockheed/Raytheon contract to build an Australian missile factory to counter threats from China; and a US Department of Energy contract to develop hydrogen propulsion technology for zero in-flight CO2 emissions, up to 80% reduction in NOx emissions and up to 35% reduction in fuel consumption.
Raytheon has a wide moat against competition based on extensive engineering know-how and close relationships with defence procurement agencies. Its products have high switching costs: long-term defence contracts typically have upgrade programmes to extend products’ lives, with substantial after-market sales. Investors get a company in a very strong position, trading on attractive valuations (see below) and with the prospect of upwards earnings revisions for the coming years if further orders come in as defence spending increases around the world.
Raytheon Technologies: a behemoth with room to grow
The Raytheon-United Technologies merger in 2020 was the biggest ever in the sector, creating a focused aerospace and defence behemoth from two firms that previously grew both organically and through smaller deals in recent years. Acquisitions included cybersecurity firms Websense and Foreground Security in 2015, Rockwell Collins in 2018, Blue Canyon Technologies, a satellite provider, in 2020 and, in 2021, FlightAware (the world���s largest flight-tracking and data platform) and SEAKR Engineering (a space electronics company).
The post-merger Raytheon reported sales of $64.4bn in 2021, up 13.8% from 2020. The company also achieved an extra $760m of synergies from the merger, taking the total to $1bn. Operating profit was $5bn, but adjusted operating profit (ie, excluding acquisition accounting adjustments) was $7.3bn. Earnings per share (EPS) was $2.6, but $4.3 on an adjusted basis. The company’s guidance for 2022 is for EPS of $4.6 to $4.8 and free cash flow of $6bn, up 20%. The 2025 targets are for a compound annual growth rate in sales of 6%-7%, expanding margins and free cash flow of at least $10bn.
Analysts’ average estimates for EPS are $4.79 for 2022, rising to $5.81 for 2023 and $6.71 for 2024. At the recent price of $103, these EPS figures give a forward price/earnings (p/e) ratio of 21.5 for 2022, falling to 17.7 for 2023 and 15.4 for 2024. However, Raytheon’s guidance was set out in January, before Russia’s invasion of Ukraine. Thus earnings could rise more (and valuations be cheaper) if the general upgrade of Western countries’ defences results in further orders.
Raytheon’s current dividend is $2.04 per share, which gives a reasonable yield of 2%. Share buybacks ($2.3bn in 2021) also support the share price. The first-quarter results are due on 26 April.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Highly qualified (BSc PhD CPhys FInstP MIoD) expert in R&D management, business improvement and investment analysis, Dr Mike Tubbs worked for decades on the 'inside' of corporate giants such as Xerox, Battelle and Lucas. Working in the research and development departments, he learnt what became the key to his investing; knowledge which gave him a unique perspective on the stock markets.
Dr Tubbs went on to create the R&D Scorecard which was presented annually to the Department of Trade & Industry and the European Commission. It was a guide for European businesses on how to improve prospects using correctly applied research and development.
He has been a contributor to MoneyWeek for many years, with a particular focus on R&D-driven growth companies.
-
Is it time to ride the recovery in emerging markets?
Interview What's the outlook for emerging markets? Gustavo Medeiros, head of research at Ashmore Group, gives his analysis and reviews progress in developing economies
-
Could the Enterprise Investment Scheme cut your tax bill?
The Enterprise Investment Scheme is tax-efficient and potentially lucrative. Taking a chance on the scheme could trim your family’s IHT bill, says David Prosser
-
'Ride the recovery in emerging markets': Gustavo Medeiros of Ashmore Group tells MoneyWeek
Interview What's the outlook for emerging markets? Gustavo Medeiros, head of research at Ashmore Group, gives his analysis and reviews progress in developing economies
-
What is the Enterprise Investment Scheme and should you have one?
The Enterprise Investment Scheme is tax-efficient and potentially lucrative. Taking a chance on the scheme could trim your family’s IHT bill, says David Prosser
-
The alcohol industry is suffering as consumers sober up – is it still worth investing in the sector?
Changing consumer tastes are rocking the alcohol industry, but the best players are adapting their strategies. Buy them while their shares are still cheap
-
A strange calm in credit
Corporate bond markets remain remarkably relaxed, with yields that offer little compensation for risks
-
The City's big bet on green finance fails to pay out
Opinion Insurers and banks are backing away from “green finance”, and there is not much sign of the green boom we were promised. That’s a problem for the City
-
Why is English football thriving – and can it last?
What has gone so right for English football? The national team has found its feet; the Premier League is swimming in money and profits are soaring
-
Six top investment trusts for smaller stocks
Liquidity constraints mean investment trusts are best placed to seize the juiciest opportunities
-
Could colour diamonds add a sparkle to your portfolio?
Diamonds of various shades never go out of fashion, says Chris Carter